Treating Depression in Patients with Ischaemic Heart Disease
Authors:
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 20 (5) , 459-465
Abstract
There are a number of dimensions to the complex relationship between cardiovascular disease and affective disorders including: (i) patients with depression are at an increased risk of dying from...Keywords
This publication has 18 references indexed in Scilit:
- Comparison of Paroxetine and Nortriptyline in Depressed Patients With Ischemic Heart DiseaseJAMA, 1998
- Interaction of ischaemia and encainide/flecainide treatment: a proposed mechanism for the increased mortality in CAST I.Heart, 1995
- Depression and 18-Month Prognosis After Myocardial InfarctionCirculation, 1995
- Effect of the Antiarrhythmic Agent Moricizine on Survival after Myocardial InfarctionNew England Journal of Medicine, 1992
- Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.Circulation, 1990
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Major depressive disorder predicts cardiac events in patients with coronary artery disease.Psychosomatic Medicine, 1988
- The Iowa Record-Linkage StudyArchives of General Psychiatry, 1985
- Mortality in Depressed Patients Treated With Electroconvulsive Therapy and AntidepressantsArchives of General Psychiatry, 1976
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960